soul trial oral semaglutide cardiovascular outcomes 2024 nejm Frontiers Emily Kronau, PharmD, MBA (@Phar_em_D)

10.1016/j.neuron.2017.09.020 Pubmed Abstract CrossRef Google Scholar View reference in article 102

PlexusDx recommends a personalized approach: begin with the Precision Peptide Genetic Test to understand your genetic predisposition to GLP-1 and GIP pathway therapy

To learn more, see the Vyvanse and drugs that increase serotonin levels section below

The Pharmacokinetics Behind the Switch Timing The 1 to 2 week washout recommendation is not arbitrary

For Fried criteria, the study used the cutoff points of hand grip and gait speed from the original study published by Fried et al 27 conducted on a Western population rather than Asian